|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
US6995006B2
(en)
|
1997-09-05 |
2006-02-07 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
PT1916258E
(pt)
|
1999-08-09 |
2014-07-29 |
Genzyme Corp |
Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
|
|
KR20090071603A
(ko)
*
|
2006-09-19 |
2009-07-01 |
노파르티스 아게 |
Ｒａｆ 억제제에 대한 표적 조절, 효능, 진단 및/또는 예후의 바이오마커
|
|
EP2104734A2
(en)
*
|
2006-12-08 |
2009-09-30 |
Asuragen, INC. |
Mir-20 regulated genes and pathways as targets for therapeutic intervention
|
|
US20100144838A1
(en)
*
|
2008-12-01 |
2010-06-10 |
Beck William T |
Methods for Identifying Modulators of Pyrimidine Tract Binding Protein
|
|
CN102858985A
(zh)
*
|
2009-07-24 |
2013-01-02 |
西格马-奥尔德里奇有限责任公司 |
基因组编辑方法
|
|
US20130209463A1
(en)
*
|
2010-06-30 |
2013-08-15 |
Compugen Ltd. |
Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders
|
|
WO2014071157A1
(en)
*
|
2012-11-01 |
2014-05-08 |
The Regents Of The University Of California |
Methods for engineering non-neuronal cells into neurons and using newly engineered neurons to treat neurodegenerative diseases
|
|
WO2017003466A1
(en)
*
|
2015-06-30 |
2017-01-05 |
University Of South Florida |
Conversion of non-neuronal cells into neurons
|
|
CN105950557B
(zh)
*
|
2016-04-22 |
2019-10-25 |
中国科学院生物物理研究所 |
一种控制人神经细胞重编程的信号通路及其应用
|
|
WO2018048877A1
(en)
*
|
2016-09-06 |
2018-03-15 |
The University Of North Carolina At Chapel Hill |
Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cells
|
|
WO2018112446A2
(en)
*
|
2016-12-18 |
2018-06-21 |
Selonterra, Inc. |
Use of apoe4 motif-mediated genes for diagnosis and treatment of alzheimer's disease
|
|
CA3096691A1
(en)
*
|
2018-04-11 |
2019-10-17 |
The Regents Of The University Of California |
Reprogramming of non-neuronal cells into neurons and methods and compositions to treat neurodegenerative diseases and disorders
|
|
WO2020113338A1
(en)
*
|
2018-12-05 |
2020-06-11 |
Adaerata, Limited Partnership |
Method of reducing neuronal microtubule binding protein tau (tau) levels
|
|
CN109913420A
(zh)
*
|
2019-03-07 |
2019-06-21 |
北京师范大学 |
Cdc20共表达基因网络作为胶质瘤治疗靶点的应用
|
|
CN109777877B
(zh)
*
|
2019-03-19 |
2022-01-04 |
宁波市第一医院 |
基于ptbp1甲基化辅助诊断脑动脉瘤的检测试剂盒及其应用
|